dichlororibofuranosylbenzimidazole has been researched along with Memory Disorders in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da Silva, WC | 1 |
| Bonini, JS | 1 |
| Bevilaqua, LR | 1 |
| Medina, JH | 1 |
| Izquierdo, I | 1 |
| Cammarota, M | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Memory Disorders
| Article | Year |
|---|---|
Inhibition of mRNA synthesis in the hippocampus impairs consolidation and reconsolidation of spatial memory.
Topics: Alpha-Amanitin; Analysis of Variance; Animals; Behavior, Animal; Dichlororibofuranosylbenzimidazole; | 2008 |